Pioneering Delix Therapeutics Study Published in ‘Science’ Elucidates the Mechanism of Psychedelic-Induced Neuroplasticity Post published:February 16, 2023 Post category:Press Release
Delix Therapeutics Partners With Cellectricon, Expressive Neuroscience and Expands Science Team To Accelerate Drug Discovery and Translatability Post published:February 14, 2023 Post category:Press Release
Delix Therapeutics Expands World-Class Team with First Head of R&D Post published:September 23, 2022 Post category:Press Release
Nature Biotechnology Selects Delix Therapeutics as a Leading Biotech Start-Up Post published:September 13, 2022 Post category:Press Release
Delix Therapeutics Closes $30 Million Convertible Note Financing, Enters $10 Million Strategic Credit Facility Option in Partnership with Comerica Bank Post published:January 10, 2022 Post category:Press Release